• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

The Neurologic Impact of COVID-19: Early Signs, Past Experience

Slideshow

As neurologic findings among patients with COVID-19 emerge, comparison to sequelae seen with other coronaviruses is instructive.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Related Content
Weekly Dose Podcast: New AD Blood Test, Elinzanetant’s Sleep Effects, Lung Cancer Screening Success, Menopause Symptom Burden, and VMS Treatment Approval

Weekly Dose Podcast: New AD Blood Test, Elinzanetant’s Sleep Effects, Lung Cancer Screening Success, Menopause Symptom Burden, and VMS Treatment Approval

Sydney Jennings
December 10th 2025
Article

Episode highlights include a new AD blood test for PCPs, sleep effects of elinzanetant among postmenopausal women, lung cancer screening gains, and more.

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 7th 2025
Podcast

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Kallyope's Oral TRPM8 Antagonist Advances Toward Registrational Studies for Acute Migraine Treatment / image credit ©Chris Harvey/Shutterstock.com

Kallyope's Oral TRPM8 Antagonist Advances Toward Registrational Studies for Acute Migraine Treatment

Grace Halsey
December 9th 2025
Article

Kallyope reported favorable phase 2b data in acute migraine for elismetrep, a novel ion channel protein, highlighting competitive efficacy and good tolerability.

Make It Routine: Screening for Cognitive Decline in Primary Care

Make It Routine: Screening for Cognitive Decline in Primary Care

Anna Chodos, MD, MPH;Sydney Jennings
July 24th 2025
Podcast

Listen to our latest podcast episode to discover how early dementia detection enhances care and quality of life, with actionable strategies for primary care teams to implement now.

Quality Improvement Program Greatly Expands Sleep Apnea Testing After Stroke in VA Hospitals / image credit ©Ridvan/stock.adobe.com

Quality Improvement Program Greatly Expands Sleep Apnea Testing After Stroke in VA Hospitals

Grace Halsey
December 8th 2025
Article

The study supports the feasibility of structured operational strategies to narrow dangerous gaps in guideline-recommended inpatient OSA testing, authors wrote.

Lecanemab Data Suggest Sustained Delay in Alzheimer Disease Progression With Long-Term Maintenance Therapy / image credit: ©Useful Items/AdobeStock

Lecanemab Data Suggest Sustained Delay in Alzheimer Disease Progression With Long-Term Maintenance Therapy

Sydney Jennings
December 5th 2025
Article

CTAD 2025: Early, continued treatment with lecanemab may delay Alzheimer disease progression by up to 8.3 years; SC dosing demonstrates bioequivalence.

© 2025 MJH Life Sciences

All rights reserved.